Literature DB >> 21488074

Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish.

Prakash C Thakur1, Carsten Stuckenholz, Marcus R Rivera, Jon M Davison, Jeffrey K Yao, Adam Amsterdam, Kirsten C Sadler, Nathan Bahary.   

Abstract

UNLABELLED: Hepatic steatosis is the initial stage of nonalcoholic fatty liver disease (NAFLD) and may predispose to more severe hepatic disease, including hepatocellular carcinoma. Endoplasmic reticulum (ER) stress has been recently implicated as a novel mechanism that may lead to NAFLD, although the genetic factors invoking ER stress are largely unknown. During a screen for liver defects from a zebrafish insertional mutant library, we isolated the mutant cdipthi559Tg/+ (hi559). CDIPT is known to play an indispensable role in phosphatidylinositol (PtdIns) synthesis. Here we show that cdipt is expressed in the developing liver, and its disruption in hi559 mutants abrogates de novo PtdIns synthesis, resulting in hepatomegaly at 5 days postfertilization. The hi559 hepatocytes display features of NAFLD, including macrovesicular steatosis, ballooning, and necroapoptosis. Gene set enrichment of microarray profiling revealed significant enrichment of endoplasmic reticulum stress response (ERSR) genes in hi559 mutants. ER stress markers, including atf6, hspa5, calr, and xbp1, are selectively up-regulated in the mutant liver. The hi559 expression profile showed significant overlap with that of mammalian hepatic ER stress and NAFLD. Ultrastructurally, the hi559 hepatocytes display marked disruption of ER architecture with hallmarks of chronic unresolved ER stress. Induction of ER stress by tunicamycin in wild-type larvae results in a fatty liver similar to hi559, suggesting that ER stress could be a fundamental mechanism contributing to hepatic steatosis.
CONCLUSION: cdipt-deficient zebrafish exhibit hepatic ER stress and NAFLD pathologies, implicating a novel link between PtdIns, ER stress, and steatosis. The tractability of hi559 mutant provides a valuable tool to dissect ERSR components, their contribution to molecular pathogenesis, and evaluation of novel therapeutics of NAFLD.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21488074      PMCID: PMC3140628          DOI: 10.1002/hep.24349

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  38 in total

Review 1.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Authors:  Ji Luo; Brendan D Manning; Lewis C Cantley
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

Review 2.  Inositol phosphates and cell signalling.

Authors:  M J Berridge; R F Irvine
Journal:  Nature       Date:  1989-09-21       Impact factor: 49.962

Review 3.  Pathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03-02       Impact factor: 46.802

4.  Identification of 315 genes essential for early zebrafish development.

Authors:  Adam Amsterdam; Robert M Nissen; Zhaoxia Sun; Eric C Swindell; Sarah Farrington; Nancy Hopkins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

Review 5.  Phosphoinositides in constitutive membrane traffic.

Authors:  Michael G Roth
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

6.  Increased phosphatidylinositol synthesis in rat embryo fibroblasts after growth stimulation and its inhibition by delta-hexachlorocyclohexane.

Authors:  R Hoffmann; P Erzberger; W Frank; H J Ristow
Journal:  Biochim Biophys Acta       Date:  1980-05-28

Review 7.  Zebrafish as a cancer model system.

Authors:  James F Amatruda; Jennifer L Shepard; Howard M Stern; Leonard I Zon
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

Review 8.  Phosphoinositide signaling disorders in human diseases.

Authors:  Caroline Pendaries; Hélène Tronchère; Monique Plantavid; Bernard Payrastre
Journal:  FEBS Lett       Date:  2003-07-03       Impact factor: 4.124

9.  Calcium and GTP: essential components in vesicular trafficking between the endoplasmic reticulum and Golgi apparatus.

Authors:  C J Beckers; W E Balch
Journal:  J Cell Biol       Date:  1989-04       Impact factor: 10.539

Review 10.  PI-loting membrane traffic.

Authors:  Maria Antonietta De Matteis; Anna Godi
Journal:  Nat Cell Biol       Date:  2004-06       Impact factor: 28.824

View more
  33 in total

1.  A highly dynamic ER-derived phosphatidylinositol-synthesizing organelle supplies phosphoinositides to cellular membranes.

Authors:  Yeun Ju Kim; Maria Luisa Guzman-Hernandez; Tamas Balla
Journal:  Dev Cell       Date:  2011-11-15       Impact factor: 12.270

2.  A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting.

Authors:  Sarah E Hugo; Lourdes Cruz-Garcia; Santhosh Karanth; Ryan M Anderson; Didier Y R Stainier; Amnon Schlegel
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

Review 3.  Zebrafish models of human liver development and disease.

Authors:  Benjamin J Wilkins; Michael Pack
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

4.  Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity.

Authors:  Cynthia D Guy; Ayako Suzuki; Manal F Abdelmalek; James L Burchette; Anna Mae Diehl
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425

5.  A genetic screen for zebrafish mutants with hepatic steatosis identifies a locus required for larval growth.

Authors:  Sarah E Hugo; Amnon Schlegel
Journal:  J Anat       Date:  2016-12-15       Impact factor: 2.610

6.  Homeostatic generation of reactive oxygen species protects the zebrafish liver from steatosis.

Authors:  Justin M Nussbaum; Liuhong J Liu; Syeda A Hasan; Madeline Schaub; Allyson McClendon; Didier Y R Stainier; Takuya F Sakaguchi
Journal:  Hepatology       Date:  2013-08-14       Impact factor: 17.425

Review 7.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

8.  Defining hepatic dysfunction parameters in two models of fatty liver disease in zebrafish larvae.

Authors:  Deanna L Howarth; Chunyue Yin; Karen Yeh; Kirsten C Sadler
Journal:  Zebrafish       Date:  2013-05-22       Impact factor: 1.985

9.  Using zebrafish to model liver diseases-Where do we stand?

Authors:  Duc-Hung Pham; Changwen Zhang; Chunyue Yin
Journal:  Curr Pathobiol Rep       Date:  2017-05-03

Review 10.  Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.

Authors:  Joost Willebrords; Isabel Veloso Alves Pereira; Michaël Maes; Sara Crespo Yanguas; Isabelle Colle; Bert Van Den Bossche; Tereza Cristina Da Silva; Cláudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Alves; Bruno Cogliati; Mathieu Vinken
Journal:  Prog Lipid Res       Date:  2015-06-11       Impact factor: 16.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.